Aptevo
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptevo and other ETFs, options, and stocks.About APVO
Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology.
CEOMarvin L. White
CEOMarvin L. White
Employees42
Employees42
HeadquartersSeattle, Washington
HeadquartersSeattle, Washington
Founded2016
Founded2016
Employees42
Employees42
APVO Key Statistics
Market cap9.67M
Market cap9.67M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume218.28K
Average volume218.28K
High today$3.10
High today$3.10
Low today$2.94
Low today$2.94
Open price$2.97
Open price$2.97
Volume129.33K
Volume129.33K
52 Week high$485.37
52 Week high$485.37
52 Week low$2.81
52 Week low$2.81
People also own
Based on the portfolios of people who own APVO. This list is generated using Robinhood data, and it’s not a recommendation.